On March 30, a District Court in Massachusetts made a final judgment to approve a class-action setlement involving First Databank and Medi-Span, two major publishers of drug pricing information.
The two firms were found to have inflated average wholesale prices (AWP) for some 400 brand-name drugs. AWP is the primary benchmark for most PBM discounts. Under the settlement, First Databank and Medi-Span agreed to roll-back the AWP on all drugs to a uniform 120% of the wholesale acquisition cost, effective Sept. 26.
With significant contract implications (and savings!) for benefits pros to consider, you can read a detailed summary of the ruling here and see EBN's coverage on taking advantage of PBM savings as a result.
Showing posts with label class-action settlement. Show all posts
Showing posts with label class-action settlement. Show all posts
Monday, April 13, 2009
Friday, March 13, 2009
Tip of the Day: Protect your AWP savings
Psst! PBMs don't want you to know about a class-action settlement involving prescription medicine pricing could result in drug-spend savings of 0.7% to 1.6% for plan sponsors. (Every penny helps these days, right?)
In a March EBN cover story, contributors Emil Kraft and Scott Rogers advice benefit managers about how some pharmacy benefit managers are attempting to reduce or eliminate the savings from the suit by changing pharmacy contracts. Don't lost out: Read the story here.
In a March EBN cover story, contributors Emil Kraft and Scott Rogers advice benefit managers about how some pharmacy benefit managers are attempting to reduce or eliminate the savings from the suit by changing pharmacy contracts. Don't lost out: Read the story here.
Subscribe to:
Posts (Atom)